138 related articles for article (PubMed ID: 9241087)
1. Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma: analysis of the literature.
Bielack SS; Beron G; Winkler K
Cancer; 1997 Aug; 80(3):516-8. PubMed ID: 9241087
[No Abstract] [Full Text] [Related]
2. Neoadjuvant chemotherapy with high-dose methotrexate in osteosarcoma.
Mir O; Ropert S; Goldwasser F
Lancet Oncol; 2008 Dec; 9(12):1198. PubMed ID: 19038767
[No Abstract] [Full Text] [Related]
3. The importance of doxorubicin and methotrexate dose intensity in the chemotherapy of osteosarcoma.
Kawai A; Sugihara S; Kunisada T; Hamada M; Inoue H
Arch Orthop Trauma Surg; 1996; 115(2):68-70. PubMed ID: 9063854
[TBL] [Abstract][Full Text] [Related]
4. High-dose methotrexate is effective in osteosarcoma so what is the problem?
Cohen IJ
J Pediatr Hematol Oncol; 2009 Dec; 31(12):892-4. PubMed ID: 19887958
[No Abstract] [Full Text] [Related]
5. High-dose methotrexate in fibroblastic osteosarcoma.
Chowbay B; Siong KK
Ann Pharmacother; 2001 Dec; 35(12):1669. PubMed ID: 11793640
[No Abstract] [Full Text] [Related]
6. Outpatient high-dose methotrexate: proceed with extreme caution, if at all.
Womer RB
Pediatr Blood Cancer; 2010 Dec; 55(7):1250-1. PubMed ID: 20981687
[No Abstract] [Full Text] [Related]
7. Accumulation of methotrexate in human tissues following high-dose methotrexate therapy.
Iqbal MP
J Pak Med Assoc; 1998 Nov; 48(11):341-3. PubMed ID: 10323057
[TBL] [Abstract][Full Text] [Related]
8. Can high dose methotrexate be continued after severe hypersensitivity reaction?
Marzollo A; Bisogno G
Pediatr Blood Cancer; 2014 Jun; 61(6):1139. PubMed ID: 24265186
[No Abstract] [Full Text] [Related]
9. The classic: recent advances in chemotherapy of metastatic osteogenic sarcoma. 1972.
Jaffe N
Clin Orthop Relat Res; 2005 Sep; 438():19-21. PubMed ID: 16131864
[No Abstract] [Full Text] [Related]
10. Efficacy of glucarpidase (carboxypeptidase g2) in patients with acute kidney injury after high-dose methotrexate therapy.
Widemann BC; Schwartz S; Jayaprakash N; Christensen R; Pui CH; Chauhan N; Daugherty C; King TR; Rush JE; Howard SC
Pharmacotherapy; 2014 May; 34(5):427-39. PubMed ID: 24132809
[TBL] [Abstract][Full Text] [Related]
11. [A case of subacute transient cerebral dysfunction in a osteosarcoma patient following high-dose methotrexate].
Yamada K; Takahashi M; Yoshida M
Gan To Kagaku Ryoho; 2002 Mar; 29(3):469-72. PubMed ID: 11915742
[TBL] [Abstract][Full Text] [Related]
12. The cytotoxic effect of methotrexate loaded bone cement on osteosarcoma cell lines.
Kim HS; Park YB; Oh JH; Yoo KH; Lee SH
Int Orthop; 2001; 25(6):343-8. PubMed ID: 11820438
[TBL] [Abstract][Full Text] [Related]
13. [Progress and stagnation in chemotherapy protocols for primary osteosarcoma].
Delépine N; Alkallaf S; Cornille H; Markowska B; Delépine G
Ann Med Interne (Paris); 2003 Feb; 154(1):12-24. PubMed ID: 12746655
[TBL] [Abstract][Full Text] [Related]
14. Ambulatory high-dose methotrexate administration among pediatric osteosarcoma patients in an urban, underserved setting is feasible, safe, and cost-effective.
Mahadeo KM; Santizo R; Baker L; Curry JO; Gorlick R; Levy AS
Pediatr Blood Cancer; 2010 Dec; 55(7):1296-9. PubMed ID: 20949591
[TBL] [Abstract][Full Text] [Related]
15. Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma. Analysis of the literature.
Delepine N; Delepine G; Bacci G; Rosen G; Desbois JC
Cancer; 1996 Nov; 78(10):2127-35. PubMed ID: 8918406
[TBL] [Abstract][Full Text] [Related]
16. Hypersensitivity reaction to high-dose methotrexate and successful rechallenge in a pediatric patient with osteosarcoma.
Scott JR; Ward DA; Crews KR; Panetta JC; Navid F
Pediatr Blood Cancer; 2014 Feb; 61(2):373-5. PubMed ID: 23955991
[TBL] [Abstract][Full Text] [Related]
17. High-dose methotrexate: the rationale..
Cheok MH; Evans WE; Kager L
J Pediatr Hematol Oncol; 2009 Mar; 31(3):224-5. PubMed ID: 19262256
[No Abstract] [Full Text] [Related]
18. Influence of the folate pathway and transporter polymorphisms on methotrexate treatment outcome in osteosarcoma.
Goričar K; Kovač V; Jazbec J; Zakotnik B; Lamovec J; Dolžan V
Pharmacogenet Genomics; 2014 Oct; 24(10):514-21. PubMed ID: 25098908
[TBL] [Abstract][Full Text] [Related]
19. Low-voltage electrochemotherapy with low-dose methotrexate enhances survival in mice with osteosarcoma.
Isobe K; Shimizu T; Nikaido T; Takaoka K
Clin Orthop Relat Res; 2004 Sep; (426):226-31. PubMed ID: 15346078
[TBL] [Abstract][Full Text] [Related]
20. Bullous acral erythema secondary to high-dose methotrexate.
Morrell DS; Challgren E; Eapen M; Esterly NB
J Pediatr Hematol Oncol; 2002; 24(3):240. PubMed ID: 11990316
[No Abstract] [Full Text] [Related]
[Next] [New Search]